Neurogene (NGNE) Shares Outstanding (Entity) (2013 - 2026)
Neurogene (NGNE) reported Shares Outstanding (Entity) of 22.55 million for Q2 2026, up 7.1% from 21.06 million a year earlier and up 1.1% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends
For FY2025, Neurogene posted Shares Outstanding (Entity) of 21.33 million, up 43.6% from FY2024.
- Shares Outstanding (Entity) has a five-year compound annual growth rate of 58.8% (FY2020 to FY2025).
- By year, Shares Outstanding (Entity) came in at 14.85 million in FY2024, 491,867 in FY2023 (-82.2%), 2.76 million in FY2022 (+0.3%) and 2.75 million in FY2021 (+30.4%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2013.
- Year over year, Shares Outstanding (Entity) has now increased in each of the last six quarters, with growth averaging 91.6% over the last seven quarters.
- The high point for year-over-year Shares Outstanding (Entity) in five years was Q3 2024 (growth of 510.9%); the low point was Q4 2023 (a decline of 82.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 22.31 million (Q1 2026), 21.33 million (Q4 2025) and 21.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Neurogene | 700.15 Mn | -397.16 Mn | - | 27.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 27.70 Mn |
| Jun 30, 2026 | 22.55 Mn |
| Mar 31, 2026 | 22.31 Mn |
| Dec 31, 2025 | 21.33 Mn |
| Sep 30, 2025 | 21.17 Mn |
| Jun 30, 2025 | 21.06 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Dec 31, 2024 | 14.85 Mn |
| Sep 30, 2024 | 16.95 Mn |
| Jun 30, 2024 | 16.94 Mn |
| Mar 31, 2024 | 16.90 Mn |
| Dec 31, 2023 | 491,867.00 |
| Sep 30, 2023 | 2.78 Mn |
| Jun 30, 2023 | 2.81 Mn |
| Mar 31, 2023 | 2.77 Mn |
| Dec 31, 2022 | 2.76 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 2.76 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 2.75 Mn |
API Access
Neurogene Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();